Cystic fibrosis gene therapy: successes, failures and hopes for the future

References

• Welsh M, Ramsey BW, Accurso F, Cutting GR. Cystic fibrosis. In: The Molecular and Metabolic Basis of Inherited Disease. Scriver CR (Ed.). McGraw-Hill, NY, USA, 5121–5188 (2001).
   Google Scholar
• Riordan JR, Rommens JM, Kerem B et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science245(4922), 1066–1073 (1989).
   PubMed Web of Science ®Google Scholar
• Alton EW, Middleton PG, Caplen NJ et al. Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet.5(2), 135–142 (1993).
   PubMed Web of Science ®Google Scholar
• Drumm ML, Pope HA, Cliff WH et al. Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer. Cell62(6), 1227–1233 (1990).
   PubMed Web of Science ®Google Scholar
• Sanders N, Rudolph C, Braeckmans K, De Smedt SC, Demeester J. Extracellular barriers in respiratory gene therapy. Adv. Drug Deliv. Rev.61(2), 115–127 (2009).
   PubMed Web of Science ®Google Scholar
• Katkin JP, Gilbert BE, Langston C et al. Aerosol delivery of a β-galactosidase adenoviral vector to the lungs of rodents. Hum. Gene Ther.6(8), 985–995 (1995).
   PubMed Web of Science ®Google Scholar
• Scaria A, St George JA, Jiang C, Kaplan JM, Wadsworth SC, Gregory RJ. Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium. J. Virol.72(9), 7302–7309 (1998).
   PubMed Web of Science ®Google Scholar
• Harvey BG, Leopold PL, Hackett NR et al. Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirus. J. Clin. Invest.104(9), 1245–1255 (1999).
   PubMed Web of Science ®Google Scholar
• Joseph PM, O’Sullivan BP, Lapey A et al. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications. Hum. Gene Ther.12(11), 1369–1382 (2001).
   PubMed Web of Science ®Google Scholar
• Walters RW, Grunst T, Bergelson JM, Finberg RW, Welsh MJ, Zabner J. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia. J. Biol. Chem.274(15) 10219–10226 (1999).
   PubMed Web of Science ®Google Scholar
• Moss RB, Rodman D, Spencer LT et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest125(2), 509–521 (2004).
   PubMed Web of Science ®Google Scholar
• Moss RB, Milla C, Colombo J et al. Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled Phase 2B trial. Hum. Gene Ther.18(8), 726–732 (2007).
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Alton EW. Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy. Adv. Drug Deliv. Rev.61(2), 128–139 (2008).
   PubMedGoogle Scholar
• Alton EW, Stern M, Farley R et al. Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet353(9157), 947–954 (1999).
   PubMed Web of Science ®Google Scholar
• Hyde SC, Southern KW, Gileadi U et al. Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther.7(13), 1156–1165 (2000).
   PubMed Web of Science ®Google Scholar
• McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet361(9370), 1671–1676 (2003).
   PubMed Web of Science ®Google Scholar
• Hyde SC, Pringle IA, Abdullah S et al. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat. Biotechnol.26(5), 549–551 (2008).
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Beckett T, Bonneau L, Young J, Kolls JK, Wang G. Transient increase in lung epithelial tight junction permeability: an additional mechanism for enhancement of lung transgene expression by perfluorochemical liquids. Mol. Ther.8(6), 927–935 (2003).
   PubMed Web of Science ®Google Scholar
• Koehler DR, Frndova H, Leung K et al. Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J. Gene Med.7(11), 1409–1420 (2005).
   PubMed Web of Science ®Google Scholar
• Price AR, Limberis MP, Wilson JM, Diamond SL. Pulmonary delivery of adenovirus vector formulated with dexamethasone–spermine facilitates homologous vector re-administration. Gene Ther.14(22), 1594–1604 (2007).
   PubMed Web of Science ®Google Scholar
• Chirmule N, Raper SE, Burkly L et al. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40–CD40 ligand interactions. J. Virol.74(7), 3345–3352 (2000).
   PubMed Web of Science ®Google Scholar
• Kolb M, Inman M, Margetts PJ, Galt T, Gauldie J. Budesonide enhances repeated gene transfer and expression in the lung with adenoviral vectors. Am. J. Respir. Crit. Care Med.164(5), 866–872 (2001).
   PubMed Web of Science ®Google Scholar
• Brunetti-Pierri N, Ng P. Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors. Gene Ther.15(8), 553–560 (2008).
   PubMed Web of Science ®Google Scholar
• Koehler DR, Sajjan U, Chow YH et al. Protection of Cftr knockout mice from acute lung infection by a helper-dependent adenoviral vector expressing Cftr in airway epithelia. Proc. Natl Acad. Sci. USA100(26), 15364–15369 (2003).
   PubMed Web of Science ®Google Scholar
• van Heeckeren AM, Scaria A, Schluchter MD et al. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection. Am. J. Physiol. Lung Cell Mol. Physiol.286(4), L717–L726 (2004).
   Web of Science ®Google Scholar
• Buckley SM, Waddington SN, Jezzard S et al. Intra-amniotic delivery of CFTR-expressing adenovirus does not reverse cystic fibrosis phenotype in inbred CFTR-knockout mice. Mol. Ther.16(5), 819–824 (2008).
   PubMed Web of Science ®Google Scholar
• Davies LA, Varathalingam A, Painter H et al. Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice. Mol. Ther.16(5), 812–818 (2008).
   PubMed Web of Science ®Google Scholar
• Limberis MP, Vandenberghe LH, Zhang L, Pickles RJ, Wilson JM. Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol. Ther.17(2), 294–301 (2009).
   PubMed Web of Science ®Google Scholar
• Xie Q, Bu W, Bhatia S et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl Acad. Sci. USA99(16), 10405–10410 (2002).
   PubMed Web of Science ®Google Scholar
• Maheshri N, Koerber JT, Kaspar BK, Schaffer DV. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors. Nat. Biotechnol.24(2), 198–204 (2006).
   PubMed Web of Science ®Google Scholar
• Excoffon KJ, Koerber JT, Dickey DD et al. Directed evolution of adeno-associated virus to an infectious respiratory virus. Proc. Natl Acad. Sci. USA106(10), 3865–3870 (2009).
   PubMed Web of Science ®Google Scholar
• Duan D, Yue Y, Engelhardt JF. Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther.4(4), 383–391 (2001).
   PubMed Web of Science ®Google Scholar
• Halbert CL, Allen JM, Miller AD. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene. Nat. Biotechnol.20(7), 697–701 (2002).
   PubMed Web of Science ®Google Scholar
• Song Y, Lou H, Boyer J et al. Functional CFTR expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Hum. Gene Ther.20(3), 267–281 (2009).
   PubMed Web of Science ®Google Scholar
• Ostedgaard LS, Rokhlina T, Karp PH et al. A shortened adeno-associated virus expression cassette for CFTR gene transfer to cystic fibrosis airway epithelia. Proc. Natl Acad. Sci. USA102(8), 2952–2957 (2005).
   PubMed Web of Science ®Google Scholar
• Fischer AC, Smith CI, Cebotaru L et al. Expression of a truncated cystic fibrosis transmembrane conductance regulator with an AAV5-pseudotyped vector in primates. Mol. Ther.15(4), 756–763 (2007).
   PubMed Web of Science ®Google Scholar
• Mueller C, Torrez D, Braag S et al. Partial correction of the CFTR-dependent ABPA mouse model with recombinant adeno-associated virus gene transfer of truncated CFTR gene. J. Gene Med.10(1), 51–60 (2008).
   PubMed Web of Science ®Google Scholar
• Allocca M, Doria M, Petrillo M et al. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J. Clin. Invest.118(5), 1955–1964 (2008).
   PubMed Web of Science ®Google Scholar
• Halbert CL, Lam SL, Miller AD. High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung. Hum. Gene Ther.18(4), 344–354 (2007).
   PubMed Web of Science ®Google Scholar
• Beck SE, Jones LA, Chesnut K et al. Repeated delivery of adeno-associated virus vectors to the rabbit airway. J. Virol.73(11), 9446–9455 (1999).
   PubMed Web of Science ®Google Scholar
• Halbert CL, Standaert TA, Aitken ML, Alexander IE, Russell DW, Miller AD. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J. Virol.71(8), 5932–5941 (1997).
   PubMed Web of Science ®Google Scholar
• Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol.74(3), 1524–1532 (2000).
   PubMed Web of Science ®Google Scholar
• Auricchio A, O’Connor E, Weiner D et al. Noninvasive gene transfer to the lung for systemic delivery of therapeutic proteins. J. Clin. Invest.110(4), 499–504 (2002).
   PubMed Web of Science ®Google Scholar
• Fischer AC, Beck SE, Smith CI et al. Successful transgene expression with serial doses of aerosolized rAAV2 vectors in rhesus macaques. Mol. Ther.8(6), 918–926 (2003).
   PubMed Web of Science ®Google Scholar
• Liu X, Luo M, Guo C et al. Analysis of adeno-associated virus progenitor cell transduction in mouse lung. Mol. Ther.17(2), 285–293 (2009).
   PubMed Web of Science ®Google Scholar
• Ding W, Yan Z, Zak R, Saavedra M, Rodman DM, Engelhardt JF. Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J. Virol.77(13), 7361–7366 (2003).
   PubMed Web of Science ®Google Scholar
• Yan Z, Lei-Butters DC, Zhang Y, Zak R, Engelhardt JF. Hybrid adeno-associated virus bearing nonhomologous inverted terminal repeats enhances dual-vector reconstruction of minigenes in vivo. Hum. Gene Ther.18(1), 81–87 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang LN, Karp P, Gerard CJ et al. Dual therapeutic utility of proteasome modulating agents for pharmaco–gene therapy of the cystic fibrosis airway. Mol. Ther.10(6), 990–1002 (2004).
   PubMed Web of Science ®Google Scholar
• Liu X, Luo M, Guo C, Yan Z, Wang Y, Engelhardt JF. Comparative biology of rAAV transduction in ferret, pig and human airway epithelia. Gene Ther.14(21), 1543–1548 (2007).
   PubMed Web of Science ®Google Scholar
• Ferrari S, Griesenbach U, Shiraki-Iida T et al. A defective nontransmissible recombinant Sendai virus mediates efficient gene transfer to airway epithelium in vivo. Gene Ther.11(22), 1659–1664 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang L, Bukreyev A, Thompson CI et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol.79(2), 1113–1124 (2005).
   PubMed Web of Science ®Google Scholar
• Ferrari S, Griesenbach U, Iida A et al. Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther.14(19), 1371–1379 (2007).
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Boyton R, Somerton L et al. Effect of tolerance induction to immunodominant T-cell epitopes of Sendai virus on gene expression following repeat administration to lung. Gene Ther.3(5), 449–456 (2006).
   Google Scholar
• Limberis M, Anson DS, Fuller M, Parsons DW. Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum. Gene Ther.13(16), 1961–1970 (2002).
   PubMed Web of Science ®Google Scholar
• Medina MF, Kobinger GP, Rux J et al. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol. Ther.8(5), 777–789 (2003).
   PubMed Web of Science ®Google Scholar
• Sinn PL, Arias AC, Brogden KA, McCray PB Jr. Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J. Virol.82(21), 10684–10692 (2008).
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Iida A, Ueda Y, Hasegawa M. Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J. Virol.77(4), 2607–2614 (2003).
   PubMed Web of Science ®Google Scholar
• Rawlins EL, Hogan BL. Ciliated epithelial cell lifespan in the mouse trachea and lung. Am. J. Physiol. Lung Cell Mol. Physiol.295(1), L231–L234 (2008).
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Mitomo K, Inoue M et al. Repeat administration of Sendai virus-F/HN pseudotyped lentivirus vector to the respiratory epithelium is feasible. Presented at: American Society of Gene Therapy’s 11th Annual Meeting. Boston, MA, USA, 21 May–1 June 2008.
   Google Scholar
• Broussau S, Jabbour N, Lachapelle G et al. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Mol. Ther.16(3), 500–507 (2008).
   PubMed Web of Science ®Google Scholar
• Xenariou S, Griesenbach U, Ferrari S et al. Using magnetic forces to enhance nonviral gene transfer to airway epithelium in vivo. Gene Ther.13(21), 1545–1552 (2006).
   PubMed Web of Science ®Google Scholar
• Xenariou S, Griesenbach U, Liang HD et al. Use of ultrasound to enhance nonviral lung gene transfer in vivo. Gene Ther.14(9), 768–774 (2007).
   PubMed Web of Science ®Google Scholar
• Griesenbach U, Meng C, Farley R et al. The role of doxorubicin in nonviral gene transfer in the lung. Biomaterials30(10), 1971–1977 (2009).
   PubMed Web of Science ®Google Scholar
• Davies LA, McLachlan G, Sumner-Jones SG et al. Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol. Ther.16(7), 1283–1290 (2008).
   PubMed Web of Science ®Google Scholar
• Gill DR, Pringle IA, Hyde SC. Progress and prospects: the design and production of plasmid vectors. Gene Ther.16(2), 165–171 (2009).
   PubMed Web of Science ®Google Scholar
• Mayrhofer P, Blaesen M, Schleef M, Jechlinger W. Minicircle-DNA production by site specific recombination and protein–DNA interaction chromatography. J. Gene Med.10(11), 1253–1269 (2008).
   PubMed Web of Science ®Google Scholar
• Kotton DN, Fine A. Lung stem cells. Cell Tissue Res.331(1), 145–156 (2008).
   PubMed Web of Science ®Google Scholar
• Dorin JR. Animal models. In: Progress in Respiratory Research: Cystic Fibrosis in the 21st Century.Bush A, Alton EW, Davies JC, Griesenbach U, Jaffe A (Eds). Karger, Basel, Switzerland, 84–92 (2006).
   Google Scholar
• Rogers CS, Hao Y, Rokhlina T et al. Production of CFTR-null and CFTR-dF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer. J. Clin. Invest.118(4), 1571–1577 (2008).
   PubMed Web of Science ®Google Scholar
• Sun X, Yan Z, Yi Y et al. Adeno-associated virus-targeted disruption of the CFTR gene in cloned ferrets. J. Clin. Invest.118(4), 1578–1583 (2008).
   PubMed Web of Science ®Google Scholar
• Rogers CS, Stoltz DA, Meyerholz DK et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science321(5897), 1837–1841 (2008).
   PubMed Web of Science ®Google Scholar
• Davies JC, Alton EWFW. Clinical outcome measures to assess new treatments for CF lung disease. In: Cystic Fibrosis (Volume 3). Hodson M, Geddes DM, Bush A (Eds). Hodder Arnold, London, UK, 375–384 (2007).
   Google Scholar